Date:8/9/2012

third-party payers and governmental organizations could adversely affect our sales and profitability; current economic conditions have and may continue to adversely affect our results of operations and financial condition; we may be unable to realize any benefit from our cost reduction and restructuring efforts and our profitability may be hurt or our business otherwise might be adversely affected; we may be unable to protect our intellectual property rights or may infringe on the intellectual property rights of others; defects or failures associated with our products and/or our quality system could lead to the filing of adverse event reports, recalls or safety alerts and negative publicity and could subject us to regulatory actions; we are currently operating under an amended consent decree with the FDA and our failure to comply with the requirements of the amended consent decree may have an adverse effect on our business; and our success depends on our key personnel, and the loss of key personnel or the transition of key personnel, including our chief executive officer, could disrupt our business. The CareFusion news release and the information contained herein reflect management's views as of Aug. 9, 2012. Except to the limited extent required by applicable law, CareFusion undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.CAREFUSION CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF INCOME(UNAUDITED)Quarter Ended Fiscal Year Ended June 30,June 30,(in millions, except per share amounts)20122011Percent Change20122011Percent ChangeRevenue

$

968

$

9403%

$

3,601$

3,4325%Cost of Products Sold47945261,7881,6717Gross Margin489488-1,8131,7613Selling, General and Administrative Expenses260288(10)1,0261,067(4)Research and Development Expenses46382116414612Restructuring and Acquisition Integration Charges711(36)3
'/>"/>

SOURCE CareFusion Corp. Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Related medicine technology :

1. CareFusion To Report Fourth Quarter And Fiscal 2012 Results On Aug. 9
2. CareFusion Expands Infusion Pump Interoperability
3. CareFusion Strengthens U.K. Presence With Acquisition of Medical Products Distributor
4. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
5. American Pacific Reports Fiscal 2012 Third Quarter Results; Full Year Guidance Improves
6. Winner Medical Reports Third Quarter Fiscal 2012 Results
7. ViroPharma Incorporated Reports Second Quarter 2012 Financial Results
8. GenVec Reports Second Quarter 2012 Financial Results
9. Cempra, Inc. Reports Second Quarter 2012 Financial and Operating Results
10. Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
11. NxStage Reports Record Revenue For The Second Quarter Of Fiscal 2012